These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 24433521

  • 1. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S, Viéitez I, Navarro C, Spuch C.
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [Abstract] [Full Text] [Related]

  • 2. Enzyme replacement therapy for lysosomal storage diseases.
    Ohashi T.
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic approaches for lysosomal storage diseases: a patent update.
    Urbanelli L, Sagini K, Polidoro M, Brozzi A, Magini A, Emiliani C.
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
    [Abstract] [Full Text] [Related]

  • 4. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L, Magini A, Polchi A, Polidoro M, Emiliani C.
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy approaches for lysosomal storage disease: next-generation treatment.
    Byrne BJ, Falk DJ, Clément N, Mah CS.
    Hum Gene Ther; 2012 Aug; 23(8):808-15. PubMed ID: 22794786
    [Abstract] [Full Text] [Related]

  • 6. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL.
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [Abstract] [Full Text] [Related]

  • 7. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics.
    Parenti G.
    EMBO Mol Med; 2009 Aug; 1(5):268-79. PubMed ID: 20049730
    [Abstract] [Full Text] [Related]

  • 8. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G, Pignata C, Vajro P, Salerno M.
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.
    Jezela-Stanek A, Chorostowska-Wynimko J, Tylki-Szymańska A.
    Clin Respir J; 2020 May; 14(5):422-429. PubMed ID: 31912638
    [Abstract] [Full Text] [Related]

  • 10. Enzyme replacement therapy for lysosomal storage diseases.
    Lachmann RH.
    Curr Opin Pediatr; 2011 Dec; 23(6):588-93. PubMed ID: 21946346
    [Abstract] [Full Text] [Related]

  • 11. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases.
    Oh DB.
    BMB Rep; 2015 Aug; 48(8):438-44. PubMed ID: 25999178
    [Abstract] [Full Text] [Related]

  • 12. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
    Li M.
    Pediatr Ann; 2018 May 01; 47(5):e191-e197. PubMed ID: 29750286
    [Abstract] [Full Text] [Related]

  • 13. Nanotechnology-based approaches for treating lysosomal storage disorders, a focus on Fabry disease.
    Abasolo I, Seras-Franzoso J, Moltó-Abad M, Díaz-Riascos V, Corchero JL, Pintos-Morell G, Schwartz S.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May 01; 13(3):e1684. PubMed ID: 33314628
    [Abstract] [Full Text] [Related]

  • 14. Personalized Pharmacoperones for Lysosomal Storage Disorder: Approach for Next-Generation Treatment.
    Haneef SA, Doss CG.
    Adv Protein Chem Struct Biol; 2016 May 01; 102():225-65. PubMed ID: 26827607
    [Abstract] [Full Text] [Related]

  • 15. Cardiac involvement in Lysosomal Storage Diseases.
    Sestito S, Parisi F, Tallarico V, Tarsitano F, Roppa K, Pensabene L, Chimenz R, Ceravolo G, Calabrò MP, De Sarro R, Moricca MT, Bonapace G, Concolino D.
    J Biol Regul Homeost Agents; 2020 May 01; 34(4 Suppl. 2):107-119. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000609
    [Abstract] [Full Text] [Related]

  • 16. Oral small molecule therapy for lysosomal storage diseases.
    Weinreb NJ.
    Pediatr Endocrinol Rev; 2013 Nov 01; 11 Suppl 1():77-90. PubMed ID: 24380126
    [Abstract] [Full Text] [Related]

  • 17. Treating lysosomal storage disorders: What have we learnt?
    Lachmann RH.
    J Inherit Metab Dis; 2020 Jan 01; 43(1):125-132. PubMed ID: 31140601
    [Abstract] [Full Text] [Related]

  • 18. [Lysosomal storage diseases in selected clinical cases].
    Banyś A, Ostróżka-Cieślik A, Sarecka-Hujar B.
    Wiad Lek; 2016 Jan 01; 69(1):43-7. PubMed ID: 27162295
    [Abstract] [Full Text] [Related]

  • 19. Treatments for lysosomal storage disorders.
    Lachmann R.
    Biochem Soc Trans; 2010 Dec 01; 38(6):1465-8. PubMed ID: 21118108
    [Abstract] [Full Text] [Related]

  • 20. Treatment options for lysosomal storage disorders: developing insights.
    van Gelder CM, Vollebregt AA, Plug I, van der Ploeg AT, Reuser AJ.
    Expert Opin Pharmacother; 2012 Nov 01; 13(16):2281-99. PubMed ID: 23009070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.